Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biovie Inc

BIVI
Current price
1.80 USD -0.08 USD (-4.26%)
Last closed 2.01 USD
ISIN US09074F2074
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 45 131 228 USD
Yield for 12 month -83.64 %
1Y
3Y
5Y
10Y
15Y
BIVI
21.11.2021 - 28.11.2021

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. Address: 680 West Nye Lane, Carson City, NV, United States, 89703

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-229 377 USD

Last Year

-266 842 USD

Current Quarter

-57 344 USD

Last Quarter

-57 344 USD

Key Figures BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -31 950 208 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -66.69 %
PEG Ratio
Return On Equity TTM -208.26 %
Wall Street Target Price 5.00 USD
Revenue TTM
Book Value 2.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -5.08 USD
Diluted Eps TTM -5.08 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BIVI

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 06.08.2024
Dividend Date 22.11.2019

Stock Valuation BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -11.66
Price Book MRQ 3.21

Financials BIVI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIVI

For 52 weeks

1.04 USD 18.90 USD
50 Day MA 2.54 USD
Shares Short Prior Month 1 346 344
200 Day MA 3.92 USD
Short Ratio 0.15
Shares Short 1 839 272
Short Percent 12.52 %